As of April 16, 2025, Pharming Group (PHAR) has a market cap of $0.56 billion USD. According to our data, Pharming Group is ranked No.5826 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.56 B |
-18.26%
|
Dec 31, 2024 | $0.68 B |
-11.94%
|
Dec 29, 2023 | $0.78 B |
3.63%
|
Dec 30, 2022 | $0.75 B |
23.38%
|
Dec 31, 2021 | $0.61 B |
-41.16%
|
Dec 31, 2020 | $1.03 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() BioCryst Pharmaceuticals
BCRX
|
$1.55 B |
-0.000 M
|
![]() USA
|
![]() Carlisle Companies
CSL
|
$15.55 B |
-0.000 M
|
![]() USA
|
![]() Takeda Pharmaceutical
TAK
|
$45.76 B |
0.002 M
|
![]() Japan
|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() Biogen
BIIB
|
$17.12 B |
0.000 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
Market Cap | = | PHAR Stock Price | * | PHAR Shares Outstanding |
= | $8.16 | * | 68.39 M | |
= | $0.56 B |